Patient 2: Achieved five (5) months of stable disease - but is now in progressive disease.
Patient 3: Achieved four (4) months of stable disease - and is still in stable disease
Patient 4: Did not achieve stable disease.
The reason why I believe Patient 2 is no longer in stable disease is in the wording of the ann.
@Steini - I agree with your comments. Also, can you imagine what would happen to the share price if they announced the results of the Case Western trial? What's the update on the complete response patient and what about the further three patients?
Three pieces of excellent news would definitely put the share price into mid one-cent range with oppies being exercised at a high rate.
Instead, it appears the only people making big money are the people in the know. And that aint us.
CHM Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)